Global network of CAP accredited laboratories. Extensive test menu.
Integrated services that cover planning, management, execution and analysis.
Insight on strategies and execution for long-term value to maximise success.
Global experience in all Phases of oncology drug development.
Experience in cardiovascular trials supported by a global team of experts.
ICON has conducted diabetes trials in all global regions.
ICON and IBM are working together to revolutionise clinical trial feasibility and patient recruitment.
Designed to enhance patient engagement and support patient recruitment and retention.
Using data to design, simulate, and analyse adaptive clinical trials with ease.
Risk-adjusted, international benchmarks on health outcomes by medical condition.
BYOD promises greater patient-centricity and will make study management less complex.
ICON sponsored research outlines partnership strategies to optimise clinical development.
25 - 28 AugustThe Convention Centre, DublinICON’s Commercialisation & Outcomes team will be exhibiting at this conference.
7 - 8 SeptemberSheraton Boston Hotel, BostonSpeak with ICON experts about optimising your clinical development strategies.
15 - 16 NovemberMarriott Hotel, LondonTransformation Strategies for a Value Driven World.
From a small team of 5 people in 1990, ICON now employs over 12,200 professionals in 37 countries.
We are committed to exceeding the quality standards demanded by our clients, patients and regulatory authorities.
Local knowledge combined with global expertise to ensure quality data on time and within budget.
ICON has assembled a leadership team with unrivaled vision and experience.
ICON provides a broad range of integrated services.
Overview of ICON Clinical Research »
Enhancing Site Performance: Firecrest Services »
We provide customised services, which can be deployed on a stand alone basis or as part of an integrated “full-service” solution. These services can support both global and locally managed projects.